A 2026 peptide enforcement timeline can mislead if every supplier headline is treated as a raid. Paradigm Peptides reached federal sentencing in July; FDA issued warning letters in August; agents searched an Apex-linked property in September. Separately, Peptide Sciences has an undated voluntary-closure notice, not a documented 2026 enforcement action. The legal stages and their evidence should not be collapsed into one crackdown.
Buy 1, Get 1 20% Off
Pick any two research compounds. Take 20% off the lower priced one.
Applied automatically at checkout, no code needed
Claim my 20% off →In every pair, the lower priced item is 20% off after other discounts; accessories excluded. For research use only.
Documented events
Kawa and Stechkober pleaded guilty. This is the start of the case chronology here, not a 2026 charge against Amino Asylum.
Source →Kawa received a 70-month sentence and Stechkober a 16-month sentence, plus restitution and a money judgment against Kawa.
Source →FDA issued warning letters citing website claims and research disclaimers. A warning letter is not a criminal conviction.
Source →Agents searched a North Sioux City business property and a nearby home; a business-record review linked Apex Peptides to related entities. No charge against Apex Peptides is established by the cited account.
Source →Undated supplier notice outside the timeline
Peptide Sciences' own notice says it voluntarily stopped selling and warns that sites claiming to be successors lack authorization. The notice gives no date, so it cannot establish a 2026 closure. Its warning about unauthorized successors is a distinct company claim, not an enforcement finding. PeptideExaminer alleges the FDA raided Amino Asylum's warehouse in June 2025 and reports a shutdown, but provides no agency case document independently confirming the allegation. Its date also puts it outside the 2026 sequence. Neither account establishes a 2026 government action against the named seller. (Peptide Sciences; Amino Asylum)
A completed sentence versus an open response window
July brought a concluded criminal sentencing step for Paradigm: Matthew Kawa received 70 months and Jennifer Stechkober 16. The DOJ sentencing release also lists $78,317.52 in restitution ordered for both and a separate $5 million money judgment against Kawa. August's Peptide Partners warning letter instead asks the named seller to answer FDA within 15 business days of receipt. Its website-claim examples show why a research-only label did not settle FDA's intended-use assessment. (Paradigm case; All five FDA letters)
The Apex search and the separate storefront notice
On September 23, agents searched 503 Prosperity Way, identified by KTIV as an Apex Waste Management property, and a Dakota Dunes home. The station distinguished nearby 498 Prosperity Way in its business-record review. KCAU reported a temporary closure notice on the Apex Peptides website the next day. The waste property search cannot establish a separate search of a peptide facility. The website notice documents the storefront on September 24, not a permanent closure. (Apex coverage)
Why the stages cannot be combined
A sentence follows guilty pleas in a criminal case. A warning letter states FDA's position and invites a response from its recipient; it is not a conviction. The Apex search is an investigative event without a disclosed purpose in the cited reports. The Peptide Sciences notice describes a voluntary company decision without a date. None proves an allegation against another seller. IQON Labs advertises here but gains no editorial certification from these events. (Separate guide to laboratory documentation)
Frequently Asked Questions
Which peptide enforcement actions are documented in 2026, and what does Peptide Sciences say?
Matthew Kawa of Paradigm Peptides was sentenced on July 30, 2026. Apex-linked properties were searched in September 2026, per local reporting. Separately, Peptide Sciences announced a voluntary shutdown in an undated company notice; its closure cannot be placed in the 2026 chronology.
Was the Paradigm Peptides case a March 2026 prosecution?
No. The guilty pleas were in December 2025. Sentencing was July 30, 2026. DOJ describes purchases from April 2019 through March 2024 for its victim-witness process.
What is the status of Amino Asylum?
PeptideExaminer reports a June 2025 warehouse raid and shutdown; no agency case document independently confirms that account here.
The next record to watch differs by event: a court docket for Paradigm, a response or further agency action for the FDA letters, and an official filing or dated company statement for Apex. Peptide Sciences’ undated notice belongs outside the 2026 enforcement chronology.
Buy 1, Get 1 20% Off
Pick any two research compounds. Take 20% off the lower priced one.
Applied automatically at checkout, no code needed
Claim my 20% off →In every pair, the lower priced item is 20% off after other discounts; accessories excluded. For research use only.
Updated September 26, 2026. Sources are linked in the timeline. For information only, not medical or legal advice. IQON Labs appears in commercial placements on this page. Research products are not for human consumption.